Skip to main content
Log in

Role of serum soluble interleukin 2-receptor in the evaluation of myocardial inflammation in patients with cardiac sarcoidosis and ventricular arrhythmias

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

All authors make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards.

References

  1. Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68:411–21.

    Article  PubMed  Google Scholar 

  2. Ribeiro Neto ML, Jellis CL, Jovce E, Callahan TD, Hachamovitch R, Culver DA. Update in cardiac sarcoidosis. Ann Am Thorac Soc. 2019;16:1341–50.

    Article  PubMed  Google Scholar 

  3. Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kavacic JC, Baughman R, Fayad ZA, Judson MA. Challenges in cardiac and pulmonary sarcoidosis: JACC state of the art review. J Am Coll Cardiol. 2020;76:1878–901.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Herkommer B, Fiek M, Reithmann C. Findings on magnetic resonance imaging of fascicular ventricular tachycardia. J Interv Card Electrophysiol. 2014;39:77–85.

    Article  PubMed  Google Scholar 

  5. Kraaijvanger R, Bonas MJ, Vorsellars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11:1143. https://doi.org/10.3389/fimmu.2020.01443.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Data collection and analysis were performed by Christopher Reithmann, Suhui Min, Theresia Kling, Bernhard Herkommer, and Michael Ulbrich. The first draft of the manuscript was written by Christopher Reithmann and all other authors commented on previous versions of the manuscript. All authors read and approved the manuscript.

Corresponding author

Correspondence to Christopher Reithmann.

Ethics declarations

Ethics approval

Ethics approval was obtained from the Ethics Committee of the Ludwig-Maximilians-University of Munich (Nr. 21–0837). All procedures performed were in accordance with the 1964 Helsinki Declaration and its later amendments.

Consent to participate and consent to publish

Written informed consent was obtained from all patients included in the study. Complete anonymity is achieved in all patients included in the study and the submission does not include information that may identify the persons.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

German Clinical Trials Register

Trial registration number DRKS0002745, date of registration 6.1.2022, retrospectively registered.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reithmann, C., Min, S., Kling, T. et al. Role of serum soluble interleukin 2-receptor in the evaluation of myocardial inflammation in patients with cardiac sarcoidosis and ventricular arrhythmias. J Interv Card Electrophysiol 65, 353–355 (2022). https://doi.org/10.1007/s10840-022-01271-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01271-4

Navigation